COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 537: Articles 5361-5370  | Next

A large-scale machine learning study of sociodemographic factors contributing to COVID-19 severity
Tumbas, M., Markovic, S., Salom, I., Djordjevic, M.
10.1101/2023.01.27.23285043 — Posted: 2023-01-29
A Case Report of a COVID-19 Infection with Positive Sputum and Negative Nasopharyngeal Rapid Antigen-Based Testing: A Practical Method to Explore Sputome
Guzman, N., Guzman, D. E.
10.1101/2023.01.26.23285052 — Posted: 2023-01-29
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
Hornsby, H., Nicols, A. R., Longet, S., Liu, C., Tomic, A., Angyal, A., Kronsteiner, B., Tyerman, J. K., Tipton, T., Zhang, P., Gallis Ramalho, M., Supasa, P., Selvaraj, M., Abraham, P., Neale, I., Ali, M., Barratt, N. A., Nell, J. M., Gustafsson, L., Strickland, S., Grouneva, I., Rostron, T., Moore, S. C., Hering, L. M., Dobson, S. L., Bibi, S., Mongkolsapaya, J., Lambe, T., Wootton, D., Hall, V., Hopkins, S., Dong, T., Barnes, E., Screaton, G., Richter, A., Turtle, L., Rowland-Jones, S. L., Carroll, M., Duncan, C. J. A., Klenerman, P., Dunachie, S. J., Payne, R. P., de Silva, T. I., The PITCH consortium
10.1101/2023.01.28.23285084 — Posted: 2023-01-29
Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice.
Singh, V. A., Nehul, S., Kumar, C. S., Banerjee, M., Kumar, P., Sharma, G., Tomar, S.
10.1101/2023.01.29.526074 — Posted: 2023-01-29
Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals.
Sokal, A., Barba-Spaeth, G., Hunault, L., Fernandez, I., Broketa, M., Meola, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Lagouge-Roussey, P., Broutin, M., Roeser, A., Bouvier-Alias, M., Crickx, E., Languille, L., Michel, M., Godeau, B., Gallien, S., Melica, G., Nguyen, Y., Canoui-Poitrine, F., Noizat-Pirenne, F., Megret, J., Pawlotsky, J.-M., Fillatreau, S., Reynaud, C.-A., Weill, J.-C., Rey, F. A., Brunhs, P., Mahevas, M., Chappert, P.
10.1101/2023.01.27.525575 — Posted: 2023-01-29
Co-evolution integrated deep learning framework for variants generation and fitness prediction
Tan, X.
10.1101/2023.01.28.526023 — Posted: 2023-01-29
Motifs in SARS-CoV-2 evolution
Barrett, C., Bura, A. C., He, Q., Huang, F. W., Li, T. J. X., Reidys, C. M.
10.1101/2023.01.27.525936 — Posted: 2023-01-29
SARS-CoV-2 Mpro protease variants of concern display altered viral and host target processing but retain potency towards antivirals
Chen, S. A., Arutyunova, E., Lu, J., Khan, M. B., Rut, W., Zmudzinski, M., Shahbaz, S., Iyyathurai, J., Moussa, E., Turner, Z., Bai, B., Lamer, T., Nieman, J. A., Vederas, J. C., Julien, O., Drag, M., Elahi, S., Young, H. S., Lemieux, M. J.
10.1101/2023.01.28.525917 — Posted: 2023-01-29
Spatiotemporal transmission of SARS-CoV-2 lineages during 2020-2021 in Pernambuco - Brazil
Machado, L. C., Dezordi, F. Z., Lima, G. B., Lima, R. E., Silva, L. A., Pereira, L. M., Silva, A. F., Neto, A. M., Oliveira, A. L. d. S., do Carmo, R. F., Armstrong, A., Silva, R. P., Loyo, R. M., Silva, B. O., Almeida, A. R., Pitta, M. G., Pereira, M. C., Santos, F. d. A. S., Siqueira, M. M., Resende, P. C., Delatorre, E., Naveca, F. G., Miyajima, F., Graf, T., Campos, T. L., Bezerra, M. F., Paiva, M. H. S., Wallau, G. d. L.
10.1101/2023.01.25.23284831 — Posted: 2023-01-28
SARS-CoV-2 Spike Protein Receptor Binding-ACE2 Interaction Increases Carbohydrate Sulfotransferases and Reduces N-Acetylgalactosamine-4-Sulfatase through Phospho-p38-MAPK and RB-E2F1
Tobacman, J. K., Bhattacharyya, S.
10.1101/2023.01.24.23284890 — Posted: 2023-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).